Bisphosphonates: a review of their pharmacokinetic properties

JH Lin - Bone, 1996 - Elsevier
Bisphosphonates are a unique class of drugs. As a family, they are characterized
pharmacologically by their ability to inhibit bone resorption, whereas, pharmacokinetically …

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

RGG Russell, PI Croucher… - Osteoporosis …, 1999 - search.proquest.com
The bisphosphonates represent a novel class of drugs, the use of which have opened up
major new approaches to the therapy of bone diseases. It has, however, taken over 30 years …

Pamidronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

A Fitton, D McTavish - Drugs, 1991 - Springer
Synopsis Pamidronate [aminohydroxypropylidene diphosphonate disodium (APD),
disodium pamidronate] is an orally and intravenously active amino-substituted …

Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants

JP Cattalini, AR Boccaccini, S Lucangioli… - … Engineering Part B …, 2012 - liebertpub.com
Bisphosphonates (BPs) are a group of well-established drugs that are applied in the
development of metabolic bone disorder-related therapies. There is increasing interest also …

Trace-level determination of phosphonates in liquid and solid phase of wastewater and environmental samples by IC-ESI-MS/MS

D Armbruster, E Rott, R Minke, O Happel - Analytical and bioanalytical …, 2020 - Springer
Phosphonates are increasingly used as water-softening agents in detergents, care products,
and industrial processes. Despite poor biodegradability, high removal rates during …

Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: A review of analytical methods

CK Zacharis, PD Tzanavaras - Journal of pharmaceutical and biomedical …, 2008 - Elsevier
Bisphosphonates is a class of chemical compounds finding extensive medical applications
against bone disorders including osteoporosis, Pagets' disease, etc. Non-N-containing …

Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum

DS Garbuz, Y Hu, WY Kim, K Duan, BA Masri… - JBJS, 2008 - journals.lww.com
Background: Porous tantalum has been shown to be effective in achieving bone ingrowth.
However, in some circumstances, bone quality or quantity may be insufficient to allow …

Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function

JR Berenson, L Rosen, R Vescio… - The Journal of …, 1997 - Wiley Online Library
Pamidronate is a second‐generation bisphosphonate that undergoes negligible
biodegradation and is eliminated exclusively by renal excretions. Nineteen cancer patients …

Improved determination of the bisphosphonate alendronate in human plasma and urine by automated precolumn derivatization and high-performance liquid …

WF Kline, BK Matuszewski - Journal of Chromatography B: Biomedical …, 1992 - Elsevier
An improved method for the determination of 4-amino-1-hydroxybutane-1, 1-bisphosphonic
acid (alendronate) in human urine and an assay in human plasma are described. The …

High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic …

MH Yun, K Kwon - Journal of pharmaceutical and biomedical analysis, 2006 - Elsevier
A high-performance liquid chromatographic (HPLC) method was developed using
diethylamine (DEA) solid-phase extraction (SPE), 9-fluorenylmethyl derivative (FMOC) and …